Medicare Advantage Meeting Sparks Controversy Over Cost and Patient Selection
WASHINGTON, D.C. – The Medicare Payment Advisory Commission (MedPAC) recently convened to discuss its annual reports on the status of the Medicare program, including the controversial findings of its report on Medicare Advantage (MA). The discussion became heated as the commission clashed over the assessment of MA’s costliness and its implications for patients’ health and healthcare financing. MedPAC’s MA status report revealed that the program’s payments were higher compared to the traditional fee-for-service (FFS) model, …